Stay updated on Epacadostat & Pembrolizumab in GIST Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.

Latest updates to the Epacadostat & Pembrolizumab in GIST Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.5.0 and deleted Revision: v3.4.3.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedMinor site revision from v3.4.1 to v3.4.2 with no changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page. No study details or user-facing content appear to be affected.SummaryDifference0.1%

- Check64 days agoChange DetectedShow glossary option added; capitalization adjusted for labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision/version updated to v3.4.0.SummaryDifference0.2%

- Check79 days agoChange DetectedOnly a behind-the-scenes revision update was made: Revision: v3.3.4 was added and Revision: v3.3.3 was removed, with no changes to study content, endpoints, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Epacadostat & Pembrolizumab in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.